What we do
We are a science-led global healthcare company. We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 86 manufacturing sites in 36 countries and large R&D centres in the UK, USA, Spain, Belgium and China.
In March 2015 we completed a 3-part transaction with Novartis which reshapes our business.
We acquired Novartis’s vaccines business (excluding influenza vaccines) and combined our Consumer Healthcare businesses to create a new company. By substantially strengthening Vaccines and Consumer Healthcare, we can deliver far-reaching benefits to patients and consumers, and further value to shareholders. In addition, Novartis acquired our marketed Oncology portfolio.
Find out more about our other sectors
We make a wide range of prescription medicines to treat many acute and chronic diseases. This is the main area of our business accounting for around 67% of our global turnover. In 2013 we distributed more than 860 million vaccine doses to 170 countries – making our vaccines business one of the largest in the world.
Our consumer healthcare products are divided into four categories: Total Wellness, Oral Care, Nutrition and Skin Health and include many well-known brands including Sensodyne, Panadol and Horlicks.
Our Pharmaceuticals business develops and makes a broad range of medicines to treat both acute and chronic diseases.
Our Vaccines business is one of the largest in the world, developing, producing and distributing over 2.5 million vaccines every day to people across 170 countries.
Our Consumer Healthcare business develops and markets a range of products in the areas of: Pain Relief, Respiratory, Oral Health, Nutrition/Gastro Intestinal and Skin Health.